000 07254nam a2200433 c4500
999 _c7227
_d7227
001 7227
003 ES-MaUEC
005 20200714183059.0
006 a||||fo|||| 00| 0
007 cr nn nnnanaaa
008 190701s2019 gw a o |||| 0|eng d
020 _a9783030059125
024 7 _a10.1007/978-3-030-05912-5
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRD598
_b.T73 2019 EB
245 0 0 _aTranscatheter Aortic Valve Implantation :
_bClinical, Interventional and Surgical Perspectives
_cedited by Arturo Giordano, Giuseppe Biondi-Zoccai, Giacomo Frati.
250 _a1st ed. 2019.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2019.
300 _a1 recurso en línea (XXIII, 558 páginas)
_b 164 ilustraciones, 135 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aI - Pathophysiological and translational perspectives -- 1 History of transcatheter aortic valve implantation -- 2 Interventional anatomy of aortic valve disease -- 3 Pathophysiology of aortic -- 4 Pathophysiology of aortic regurigation -- 5 Pathophysiology of degenerated bioprosthesis -- 6 Role of inflammation in native and prosthetic aortic valve disease -- 7 Predictive computational models of transcatheter aortic valve implantation -- 8 Hemodynamic issues with transcatheter aortic valve implantation -- 9 Risk scores for aortic valve -- II Clinical perspectives -- 10 Role of rest and stress echocardiography in transcatheter aortic valve implantation -- 11 Role of computed tomography in transcatheter aortic valve implantation -- 12 Role of magnetic resonance imaging in transcatheter aortic valve implantation -- 13 Concomitant coronary artery disease and aortic stenosis -- 14 Comparison of transcatheter aortic valve implantation to medical therapy in prohibitive risk patients -- 15 Clinical and imaging follow-up after transcatheter aortic valve implantation -- 16 Biomarkers before, during and after transcatheter aortic valve implantation -- 17 Prognostic impact of aortic regurgitation and paravalvular leak -- 18 Leaflet motion abnormalities -- 19 Gender-related differences in transcatheter aortic valve implantation -- 20 Implementation issues for transcatheter aortic valve implantation: cost-effectiveness, wait-times and volume-outcome balance -- III Interventional perspectives -- 21 Transfemoral access management for transcatheter aortic valve implantation -- 22 Challenging anathomy for transcatheter aortic valve implantation -- 23 Abbott Vascular program for transcatheter aortic valve implantation -- 24 Boston Scientific program for transcatheter aortic valve implantation -- 25 Edwards program for transcatheter aortic valve implantation -- 26 JenaValve program for transcatheter aortic valve implantation -- 27 Medtronic program for transcatheter aortic valve implantation -- 28 Self-expanding vs balloon-expandable devices for transcatheter aortic valve implantation -- 29 Individualized device choice for transcatheter aortic valve implantation -- 30 Predilation for transcatheter aortic valve implantation -- 31 Postdilation for transcatheter aortic valve implantation -- 32 Embolic protection devices for transcatheter aortic valve implantation -- 33 Antithrombotic therapy during and after transcatheter aortic valve implantation -- 34 Contrast induced nephropathy and transcatheter aortic valve implantation -- 35 Conduction disorders and permanent pacemaker requirement after transcatheter aortic valve implantation -- 36 Systolic dysfunction and hemodynamic support in patients candidate for transcatheter aortic valve implantation -- 37 Radiation exposure in transcatheter aortic valve implantation -- 38 Procedure efficiency in transcatheter aortic valve implantation -- 39 Predictors of success for transcatheter aortic valve implantation -- 40 Learning curve, procedural volumes and relationship with clinical outcomes for transcatheter aortic valve implantation -- 41 Aortic valvuloplasty as bridge vs destination therapy -- IV Surgical perspectives -- 42 Role of the heart team in decision making for transcatheter aortic valve implantation -- 43 Alternative accesses for transcatheter aortic valve implantation -- 44 Comparison of transcatheter aortic valve implantation to surgery in intermediate risk patients -- 45 New approaches for aortic valve disease: from transcatheter aortic valve implantation to sutureless aortic valves -- 46 Hybrid procedures for aortic valve disease: transapical aortic valve implantation through lower left anterior mini-thoracotomy vs Edwards Intuity valve implantation through upper right anterior mini-thoracotomy -- V Future perspectives -- 47 Medical treatment for aortic valve disease -- 48 Transcatheter aortic valve implantation for pure aortic regurgitation -- 49 New-generation devices for transcatheter aortic valve implantation -- 50 Bioresorbable valve for transcatheter aortic valve implantation: tomorrow's world from preclinical to clinical -- 51 Focus on transcatheter aortic valve implantation in low risk patients -- 52 Conclusion.
520 3 _aThis book provides comprehensive information on transcatheter aortic valve implantation (TAVI), which was introduced for the treatment of aortic valve disease less than two decades ago. It explains how TAVI has delivered satisfactory results even in high and intermediate risk patients and outlines how it continues to evolve, thus requiring awareness of state of the art approaches to indication, risk stratification, device choice, procedure, and follow-up. In addition, it reports on the complex and multidisciplinary approach needed to maximize the efficacy, safety, and appropriateness of TAVI, providing detailed clinical, interventional and surgical perspectives focusing on the development of this cardiovascular intervention. Starting with the history of TAVI, addressing the interventional anatomy of aortic valve disease, and reporting on the expert authors' day-to-day experiences, this highly informative book offers an essential update for all cardiologists and surgeons interested in transcatheter aortic valve implantation, as well as any clinician, decision-maker and stakeholder involved in patient selection, procedural management, and follow-up.
988 _aSegundosemestre_2019_Medicine
650 7 _9138127
_aCorazón
_2embne
700 1 _aGiordano, Arturo
_eeditor
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aBiondi-Zoccai, Giuseppe
_eeditor
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
_997836
700 1 _aFrati, Giacomo
_eeditor
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106937
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9783030059118
776 0 8 _iPrinted edition:
_z9783030059132
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-05912-5
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0
_zSI